20 May 2026
EU Pharmaceutical Package | Part I – Regulatory Data & Market Protection, Orphan Market Exclusivity, Bolar Exemption and Antimicrobial Vouchers
15 min read
This is our first news alert on the pharmaceutical package, as released in March 2026, addressing four commercially critical areas: (i) regulatory data and market protection; (ii) market exclusivity for orphan medicinal products; (iii) the Bolar exemption; and (iv) the new transferable exclusivity vouchers for priority antimicrobials.
See more via the below note
Attachments:
Key contacts
->
News & insights
1 min
read
read
Briefings
The online withdrawal button: A new mandatory obligation for online traders
9 June 2026
5 min
read
read
Briefings
Alleged Anticompetitive Bundling of MS Treatment & Diagnostic – Italian Competition Authority Investigates Biogen
29 May 2026
10 min
read
read
Briefings
CJEU Rules that EU Member States Cannot Restrict Online Sale of Non-Prescription Medicinal Products to Single Subcategory on Public Health Grounds
26 May 2026
15 min
read
read
Briefings
Deckers v. Up & Running: English Court of Appeal confirms brands’ ability to control online sales without infringing competition law
21 May 2026
10 min
read
read
Briefings
Technology Transfer Agreements – New EU and UK Competition Law Frameworks
18 May 2026
3 min
read
read
Briefings
Belgian Competition Authority Orders AutoScout24 to Restore Data Portability to Competing Platform Subject to Penalty Payments
5 May 2026
1 min
read
read
Briefings
European Commission issues new draft merger control guidelines, launches public consultation
30 April 2026
1 min
read
read
Briefings
First CMA Consumer Fine Shows Commitment to Enforce New Regime
29 April 2026
